Chugai Pharmaceutical Co. Ltd.

CHGCY | OTC

Price Alert Chart Builder DCF Calculator

$21.56

-$0.10 (-0.46%)

At close: Sep 23, 2026, 3:28 PM ET

$21.47

-$0.09 (-0.42%)

After-hours: Sep 23, 2026, 4:01 PM ET

Overview Rating Statistics Financials Earnings Ownership Dividends Profile

-0.46%

(1D)

Rating

Updated: Sep 24, 2026

62.2

Fundamentals Strong

Market Sentiment Neutral

Moat Wide

Full Analysis

Key Statistics

Market Data

Market Cap $70.98B

1D Range

20.94 21.66

52W Range

20 34.84

Valuation (TTM)

PE 11.61

PB 5.69

EV/EBITDA 15.39

Valuation (NTM)

Forward PE 17.82

Forward PEG 1.34

Price Target N/A

Cash Flow

FCF Yield 3.6%

SBC Adj. FCF Yield 3.6%

SBC Impact N/A

Margins

Gross Margin 71.4%

Operating Margin 47.2%

FCF Margin 30.2%

Growth (CAGR)

Revenue 3Y | 5Y 2.6% | 10.7%

Dil EPS 3Y | 5Y 13.0% | 15.4%

FCF 3Y | 5Y 29.8% | 15.8%

Returns

ROA 19.2%

ROE 24.0%

ROIC 22.2%

Financial Health

Net Cash

¥962.57B ($5.92B)

Current Ratio 4.35

Interest Coverage 652.57

Dividends

Div Yield 5.80%

Payout Ratio 0.4%

FCF Payout Ratio 110.5%

All Key Statistics

Loading financial charts...

Profile

A detailed description of the company is not yet available.

Sector n/a

Industry n/a

Employees n/a

IPO Date n/a

Website n/a

Fiscal Year n/a

Full Company Profile

Latest News

1 month ago · defenseworld.net

Short Interest in Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (OTCMKTS:CHGCY) Decreases By 54.9%

Chugai Pharmaceutical Co., Ltd. Unsponsored ADR (OTCMKTS:CHGCY - Get Free Report) was the target of a large drop in short interest in the month of July. As of July 31st, there was short interest totaling 28,818 shares, a drop of 54.9% from the July 15th total of 63,921 shares. Currently, 0.0% of the shares of

2 months ago · seekingalpha.com

Chugai Pharmaceutical Co., Ltd. (CHGCY) Q2 2026 Earnings Call Transcript